Skip to content

Comparing of extralevator abdominoperineal resection and abdominoperineal resection under laparoscopic in lower rectal cancer: A retrospective cohort study

Comparing of extralevator abdominoperineal resection and abdominoperineal resection under laparoscopic in lower rectal cancer: A retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023417
Enrollment
Unknown
Registered
2019-05-26
Start date
2009-09-01
Completion date
Unknown
Last updated
2019-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower rectal cancer

Interventions

Group 1:Laparoscopic extralevator abdominoperineal resection (LELAPR)
Group 2:Laparoscopic abdominoperineal resection(LAPR)

Sponsors

Peking University Cancer Hospital & Institute
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Preoperative MRI and electron colonoscopy confirmed primary rectal cancer; 2.=5 cm from the anal verge to the lower margin of the tumor; 3.Inclusion age: 18-80 years old; 4.Inclusion time: September 2009 - December 2015.

Exclusion criteria

Exclusion criteria: 1.Combined with acute complications such as complete intestinal obstruction, major bleeding, and perforation; 2.Metasis existing; 3.Surgical contraindications existing; 4.Pregnancy,lactating femal.

Design outcomes

Primary

MeasureTime frame
Circumferential resection margin rate;Intraoperative perforation rate;Local recurrence;Metastasis;Overall survival;Disease-free survival;Progression-free survival;Death;

Secondary

MeasureTime frame
Operation time;Intraoperative blood loss;Hospitalization after surgery;Lymph nodes examined;Positive lymph nodes;Maximum tumor diameter;Postoperative hernia;Postoperative urinary retention;Postoperative intestinal obstruction;Postoperative perineal wound complications;pCR;

Countries

China

Contacts

Public ContactMing Cui

Peking University Cancer Hospital & Institute

cuiming@bjmu.edu.cn+86 13366527310

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026